Company profile
NewStem company profile
NewStem is a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness. NewStem is a spinoff of Yissum, The Technology Transfer Company of The Hebrew University. NewStem's technology can predict patients' resistance to chemotherapy allowing for better, targeted cancer treatments and the potential to reduce resistance to chemotherapy.
Business identity
- Website
- https://newstem.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2016-09-01, Month
Headquarters
- Headquarters
- Sumbul, North Sumatra, Indonesia
- Country code
- ID
- Continent
- Asia